
    
      This is a non-interventional, descriptive, national, multi-site, longitudinal and prospective
      observational study with in-patients adults or minors undergoing cytotoxic chemotherapy,
      being treated prophylactically with Nivestimâ„¢ in order to reduce the duration of neutropenia
      and to reduce the incidence of chemotherapy-induced Febrile neutropenia (FN).
    
  